QA: AXIM Biotechnologies INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001514946_2024_AXIM_Biotechnologies_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001514946, AXIM Biotechnologies INC

  xvar xval
0 AssetsCurrent 156,457
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 134,067
3 remainder_Assets 3,831,024
4 LiabilitiesCurrent 5,978,417
5 LiabilitiesNoncurrent 5,799,778
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,966,173
9 ResearchAndDevelopmentExpense 119,758
10 remainder_Expenses 427,020
11 remainder_Revenues 40,218
12 remainder_NetIncome 23,812,327
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 4,121,548
1 Liabilities 11,778,195
2 Expenses 2,512,951
3 Revenues 40,218
4 StockholdersEquity -7,656,647
5 NetIncome 21,339,594
6 ComprehensiveNetIncome 21,339,594
7 BaseVar 21,132,620
8 EconomicCapitalRatiobeforeLimitedLiability 0.585
9 EconomicCapitalRatio 1.96

Edgar->Model Mapping

Feature Distribution

Change over Time